Nov 30, 2016, PEYE OTC Disclosure & News Service – GARDNER, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) announced today that it has sold units of stock and warrants to accredited investors in a private placement with 1,333,334 units consisting of (i) an aggregate of 1,333,334 shares of common stock, and (ii) warrants to purchase up to 666,667 shares of common stock. The unit price is $0.60. The warrant exercise price is variableRead more
- Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing Facility in India
- Cannabis Strategic Files Provision Patent for Unique Cannabis Smoke Filtration Device
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
- Pura Naturals Launches New Line of Health and Beauty Products with CBD and Hemp Seed Oils
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More